Wall Street analysts expect AmerisourceBergen Corp. (NYSE:ABC) to announce earnings of $1.69 per share for the current quarter, according to Zacks. Five analysts have issued estimates for AmerisourceBergen’s earnings. The lowest EPS estimate is $1.59 and the highest is $1.77. AmerisourceBergen posted earnings per share of $1.60 during the same quarter last year, which indicates a positive year over year growth rate of 5.6%. The business is expected to issue its next earnings report on Thursday, January 30th.
On average, analysts expect that AmerisourceBergen will report full-year earnings of $7.54 per share for the current year, with EPS estimates ranging from $7.42 to $7.60. For the next fiscal year, analysts expect that the business will report earnings of $8.10 per share, with EPS estimates ranging from $7.52 to $8.31. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that cover AmerisourceBergen.
AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings results on Thursday, November 7th. The company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.58 by $0.03. AmerisourceBergen had a net margin of 0.48% and a return on equity of 48.84%. The firm had revenue of $45.64 billion during the quarter, compared to analyst estimates of $45.15 billion. During the same quarter in the prior year, the business posted $1.45 earnings per share. AmerisourceBergen’s revenue for the quarter was up 5.4% compared to the same quarter last year.
Several equities analysts recently commented on ABC shares. ValuEngine lowered shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a research report on Friday, November 1st. Deutsche Bank started coverage on shares of AmerisourceBergen in a research report on Thursday, September 12th. They issued a “hold” rating and a $91.00 price objective for the company. Morgan Stanley dropped their price objective on shares of AmerisourceBergen from $91.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, September 6th. TheStreet raised shares of AmerisourceBergen from a “c+” rating to a “b-” rating in a research report on Friday, December 6th. Finally, Argus reissued a “buy” rating and issued a $110.00 price objective on shares of AmerisourceBergen in a research report on Monday, November 18th. Two analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $88.86.
In other news, EVP Gina Clark sold 7,800 shares of the company’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $84.96, for a total value of $662,688.00. Following the completion of the transaction, the executive vice president now directly owns 23,595 shares in the company, valued at $2,004,631.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Steven H. Collis sold 19,905 shares of the company’s stock in a transaction on Monday, October 7th. The shares were sold at an average price of $82.12, for a total transaction of $1,634,598.60. Following the completion of the transaction, the chief executive officer now owns 154,484 shares of the company’s stock, valued at $12,686,226.08. The disclosure for this sale can be found here. Insiders sold 86,521 shares of company stock valued at $7,319,222 in the last three months. Company insiders own 27.80% of the company’s stock.
Several hedge funds have recently made changes to their positions in ABC. Vanguard Group Inc. boosted its stake in shares of AmerisourceBergen by 16.8% in the second quarter. Vanguard Group Inc. now owns 18,910,594 shares of the company’s stock valued at $1,612,318,000 after purchasing an additional 2,719,868 shares during the period. Amundi Pioneer Asset Management Inc. boosted its stake in shares of AmerisourceBergen by 493.2% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 757,887 shares of the company’s stock valued at $64,617,000 after purchasing an additional 630,123 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its stake in shares of AmerisourceBergen by 1,584.3% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 490,101 shares of the company’s stock valued at $41,786,000 after purchasing an additional 461,002 shares during the period. Nuveen Asset Management LLC boosted its stake in shares of AmerisourceBergen by 111.5% in the second quarter. Nuveen Asset Management LLC now owns 738,360 shares of the company’s stock valued at $62,953,000 after purchasing an additional 389,252 shares during the period. Finally, Victory Capital Management Inc. boosted its stake in shares of AmerisourceBergen by 9.7% in the second quarter. Victory Capital Management Inc. now owns 2,769,023 shares of the company’s stock valued at $236,087,000 after purchasing an additional 245,394 shares during the period. Institutional investors and hedge funds own 66.77% of the company’s stock.
ABC stock traded down $1.94 on Friday, hitting $84.85. 977,009 shares of the company were exchanged, compared to its average volume of 947,265. AmerisourceBergen has a twelve month low of $69.36 and a twelve month high of $94.75. The company has a debt-to-equity ratio of 1.45, a current ratio of 0.95 and a quick ratio of 0.58. The business’s fifty day moving average is $87.22 and its two-hundred day moving average is $85.56. The stock has a market capitalization of $17.85 billion, a price-to-earnings ratio of 11.97, a price-to-earnings-growth ratio of 1.47 and a beta of 0.97.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Monday, November 18th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.89%. The ex-dividend date was Friday, November 15th. AmerisourceBergen’s payout ratio is currently 22.57%.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
See Also: What does a market perform rating mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.